James Daly

Mr. James M.
Daly is an Independent Director at Cytokinetics, Inc., an Independent Director at Madrigal Pharmaceuticals, Inc. and an Independent Director at ACADIA Pharmaceuticals, Inc. He is on the Board of Directors at Halozyme Therapeutics, Inc., Cytokinetics, Inc., Madrigal Pharmaceuticals, Inc. and ACADIA Pharmaceuticals, Inc. Mr. Daly was previously employed as an Independent Non-Executive Director by argenx SE, an Independent Director by Bellicum Pharmaceuticals, Inc., an Independent Director by Chimerix, Inc., a Chief Commercial Officer & Executive VP by Incyte Corp., a Senior Vice President by Amgen Ventures LLC, a SVP-Global Marketing & Commercial Development by Amgen, Inc., a Senior Vice President-Respiratory Division by Smithkline Beecham Corp., and a Principal by Francis Cauffman, Inc. He also served on the board at Coherus Oncology, Inc. He received his undergraduate degree from State University of New York at Buffalo and an MBA from State University of New York at Buffalo.